Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy

AUTOR(ES)

Kawano, Daniel Fábio, Silva, Vinicius Barreto da, Jorge, Daniel Macedo de Melo, Silva, Carlos Henrique Tomich de Paula da, Carvalho, Ivone

FONTE

Mem. Inst. Oswaldo Cruz

DATA DE PUBLICAÇÃO

2011-12

RESUMO

Chagas disease (CD) causes the highest burden of parasitic diseases in the Western Hemisphere and is therefore a priority for drug research and development. Platelet-activating factor (PAF) causes the CD parasite Trypanosoma cruzi to differentiate, which suggests that the parasite may express PAF receptors. Here, we explored the T. cruzi proteome for PAF receptor-like proteins. From a total of 23,000 protein sequences, we identified 29 hypothetical proteins that are predicted to have seven transmembrane domains (TMDs), which is the main characteristic of the G protein-coupled receptors (GPCRs), including the PAF receptor. The TMDs of these sequences were independently aligned with domains from 25 animal PAF receptors and the sequences were analysed for conserved residues. The conservation score mean values for the TMDs of the hypothetical proteins ranged from 31.7-44.1%, which suggests that if the putative T. cruzi PAF receptor is among the sequences identified, the TMDs are not highly conserved. These results suggest that T. cruzi contains several GPCR-like proteins and that one of these GPCRs may be a PAF receptor. Future studies may further validate the PAF receptor as a target for CD chemotherapy.

Documentos Relacionados

• Inositol metabolism in Trypanosoma cruzi: potential target for chemotherapy against Chagas' disease
• The pentose phosphate pathway in Trypanosoma cruzi: a potential target for the chemotherapy of Chagas disease
• Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis.
• Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.
• Allergy and Immunology: Platelet-Activating Factor